Human microsomal epoxide hydrolase:: 5′-flanking region genetic polymorphisms

被引:53
作者
Raaka, S [1 ]
Hassett, C [1 ]
Omiecinski, CJ [1 ]
机构
[1] Univ Washington, Dept Environm Hlth, Seattle, WA 98105 USA
关键词
D O I
10.1093/carcin/19.3.387
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Microsomal epoxide hydrolase (mEH) catalyses the hydrolysis of xenobiotic epoxides, including various epoxide derivatives of the procarcinogenic polyaromatic hydrocarbons, Levels of mEH enzymatic activity among different cell types and between individuals within the population vary considerably. Genetic polymorphisms within the structural region of the human mEH gene exist and appear to contribute to the population variance in functional expression. In this study, we used single strand conformational polymorphism analysis and direct DNA sequencing approaches to identify seven additional polymorphic sites within the upstream region of the mEH gene, spanning -743 to +185 bp, relative to the transcription initiation site. Allelic frequencies and linkages of the polymorphic nucleotides were determined in 51 individuals using restriction fragment length polymorphism or competitive oligonucleotide priming assays. To determine the functional significance of the individual nucleotide substitutions, DNA fragments representing the variant alleles were cloned into the heterologous pBRAMScat2 reporter vector, transfected into HepG2 cells and assessed for reporter gene expression. Results indicated that certain of these polymorphic loci might differentially regulate transcription, with the maximum contribution of any of the variants modifying levels of reporter gene activity by similar to 30%. These observations establish that genetic variation in the 5' flanking sequence of mEH gene is likely an additional contributing factor to the range of functional mEH expression existing in human populations.
引用
收藏
页码:387 / 393
页数:7
相关论文
共 43 条
  • [1] [Anonymous], 1986, HUMAN GENETICS PROBL
  • [2] SECRETED PLACENTAL ALKALINE-PHOSPHATASE - A POWERFUL NEW QUANTITATIVE INDICATOR OF GENE-EXPRESSION IN EUKARYOTIC CELLS
    BERGER, J
    HAUBER, J
    HAUBER, R
    GEIGER, R
    CULLEN, BR
    [J]. GENE, 1988, 66 (01) : 1 - 10
  • [3] Boulikas Teni, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P117
  • [4] PRENATAL PREDICTION OF RISK OF THE FETAL HYDANTOIN SYNDROME
    BUEHLER, BA
    DELIMONT, D
    VANWAES, M
    FINNELL, RH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (22) : 1567 - 1572
  • [5] CHECKOWAY H, 1992, BRIT J IND MED, V49, P560
  • [6] AN ESTIMATE OF UNIQUE DNA-SEQUENCE HETEROZYGOSITY IN THE HUMAN GENOME
    COOPER, DN
    SMITH, BA
    COOKE, HJ
    NIEMANN, S
    SCHMIDTKE, J
    [J]. HUMAN GENETICS, 1985, 69 (03) : 201 - 205
  • [7] NUCLEAR FACTOR-I AND ACTIVATOR PROTEIN-2 BIND IN A MUTUALLY EXCLUSIVE WAY TO OVERLAPPING PROMOTER SEQUENCES AND TRANS-ACTIVATE THE HUMAN GROWTH-HORMONE GENE
    COURTOIS, SJ
    LAFONTAINE, DA
    LEMAIGRE, FP
    DURVIAUX, SM
    ROUSSEAU, GG
    [J]. NUCLEIC ACIDS RESEARCH, 1990, 18 (01) : 57 - 64
  • [8] AN APOLIPOPROTEIN CIII HAPLOTYPE PROTECTIVE AGAINST HYPERTRIGLYCERIDEMIA IS SPECIFIED BY PROMOTER AND 3' UNTRANSLATED REGION POLYMORPHISMS
    DAMMERMAN, M
    SANDKUIJL, LA
    HALAAS, JL
    CHUNG, W
    BRESLOW, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) : 4562 - 4566
  • [9] KINETIC-PARAMETERS OF LYMPHOCYTE MICROSOMAL EPOXIDE HYDROLASE IN CARBAMAZEPINE HYPERSENSITIVE PATIENTS - ASSESSMENT BY RADIOMETRIC HPLC
    DAVIS, CD
    PIRMOHAMED, M
    KITTERINGHAM, NR
    ALLOTT, RL
    SMITH, D
    PARK, BK
    [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 50 (09) : 1361 - 1366
  • [10] ETTER HU, 1991, J BIOL CHEM, V266, P18600